Structures of thymus and activation-regulated chemokine (TARC)

被引:16
作者
Asojo, OA
Boulègue, C
Hoover, DM
Lu, WY
Lubkowski, J [1 ]
机构
[1] NCI, Macromol Crystallog Lab, Frederick, MD 21702 USA
[2] Univ Maryland, Inst Biotechnol, Inst Human virol, Baltimore, MD 21201 USA
来源
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY | 2003年 / 59卷
关键词
CC-CHEMOKINE; MOLECULAR REPLACEMENT; X-RAY; RECEPTOR; EXPRESSION; CELLS; MOLSCRIPT; CLONING; GAMMA; MICE;
D O I
10.1107/S0907444903009454
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Thymus and activation-regulated chemokine (TARC) is a CC chemokine that is mainly expressed in the thymus. TARC interacts primarily with the CCR4 receptor and to a lesser extent with the CCR8 receptor. The structures of TARC have been solved by molecular replacement in two space groups, triclinic (P1) and tetragonal (P4(1)), and refined to resolutions of 1.72 and 2.1 Angstrom, respectively, with R factors of 19.8% (R-free = 24.1%) and 19.8% (R-free = 27.7%), respectively. The search model originated from the crystal structure of another chemokine, RANTES, and proved to be only modestly similar to the refined structure of TARC. Whereas the tetragonal structure was easily solved using the program AMoRe, solution of the triclinic structure proved to be quite challenging and was obtained by combining the results from four different molecular-replacement programs (AMoRe, CNS, BEAST and EPMR), with subsequent extension of the gathered information. The tertiary structure of TARC is similar to that of other CC chemokines, with a three-stranded antiparallel beta-sheet flanked by a C-terminal helix. Both quaternary structures consist of dimers, which in the triclinic crystals pack further into tetramers. The TARC dimers are similar to those observed previously in the crystal structures of both MCP-1 and RANTES.
引用
收藏
页码:1165 / 1173
页数:9
相关论文
共 34 条
  • [1] Crystallization and preliminary X-ray studies of thymus and activation-regulated chemokine (TARC)
    Asojo, OA
    Cater, S
    Hoover, DM
    Boulègue, C
    Lu, WY
    Lubkowski, J
    [J]. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 2003, 59 : 163 - 165
  • [2] Bernardini G, 1998, EUR J IMMUNOL, V28, P582, DOI 10.1002/(SICI)1521-4141(199802)28:02<582::AID-IMMU582>3.3.CO
  • [3] 2-1
  • [4] Divergent effects of interleukin-4 and interferon-γ on macrophage-derived chemokine Production:: An amplification circuit of polarized T helper 2 responses
    Bonecchi, R
    Sozzani, S
    Stine, JT
    Luini, W
    D'Amico, G
    Allavena, P
    Chantry, D
    Mantovani, A
    [J]. BLOOD, 1998, 92 (08) : 2668 - 2671
  • [5] Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254
  • [6] Molecular replacement using genetic algorithms
    Chang, G
    Lewis, M
    [J]. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1997, 53 : 279 - 289
  • [7] D'Ambrosio D, 1998, J IMMUNOL, V161, P5111
  • [8] An extensively modified version of MolScript that includes greatly enhanced coloring capabilities
    Esnouf, RM
    [J]. JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 1997, 15 (02) : 132 - +
  • [9] Multidimensional molecular replacement
    Glykos, NM
    Kokkinidis, M
    [J]. ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2001, 57 : 1462 - 1473
  • [10] Human macrophage-derived chemokine (MDC), a novel chemoattractant for monocytes, monocyte-derived dendritic cells, and natural killer cells
    Godiska, R
    Chantry, D
    Raport, CJ
    Sozzani, S
    Allavena, P
    Leviten, D
    Mantovani, A
    Gray, PW
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (09) : 1595 - 1604